Copyright Reports & Markets. All rights reserved.

(Post-pandemic Era)-Global Lung Cancer Liquid Biops Market Segment Research Report 2022

Buy now

Table of Contents

    Global Lung Cancer Liquid Biops Market Segment Research Report 2022

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global Lung Cancer Liquid Biops Market by Value
          • 2.2.1 Global Lung Cancer Liquid Biops Revenue by Type
          • 2.2.2 Global Lung Cancer Liquid Biops Market by Value (%)
        • 2.3 Global Lung Cancer Liquid Biops Market by Production
          • 2.3.1 Global Lung Cancer Liquid Biops Production by Type
          • 2.3.2 Global Lung Cancer Liquid Biops Market by Production (%)

        3. The Major Driver of Lung Cancer Liquid Biops Industry

        • 3.1 Historical & Forecast Global Lung Cancer Liquid Biops Demand
        • 3.2 Largest Application for Lung Cancer Liquid Biops (2018-2028)
        • 3.3 The Major Downstream Company in China Market 2022

        4. Global and Regional Lung Cancer Liquid Biops Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2022)
        • 4.2 Regional Market Share in Terms of Revenue (2018-2022)
        • 4.3 Concentration Ratio (CR5& CR10) of Lung Cancer Liquid Biops Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US Lung Cancer Liquid Biops Production, Demand (2018-2028)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        6. Europe Lung Cancer Liquid Biops Production, Demand (2018-2028)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        7. China Lung Cancer Liquid Biops Production, Demand (2018-2028)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        8. Japan Lung Cancer Liquid Biops Production, Demand (2018-2028)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        9. India Lung Cancer Liquid Biops Production, Demand (2018-2028)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        10. Korea Lung Cancer Liquid Biops Production, Demand (2018-2028)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        11. Southeast Asia Lung Cancer Liquid Biops Production, Demand (2018-2028)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        12. Global Lung Cancer Liquid Biops Average Price Trend

        • 12.1 Market Price for Each Type of Lung Cancer Liquid Biops in US (2018-2022)
        • 12.2 Market Price for Each Type of Lung Cancer Liquid Biops in Europe (2018-2022)
        • 12.3 Market Price for Each Type of Lung Cancer Liquid Biops in China (2018-2022)
        • 12.4 Market Price for Each Type of Lung Cancer Liquid Biops in Japan (2018-2022)
        • 12.5 Market Price for Each Type of Lung Cancer Liquid Biops in India (2018-2022)
        • 12.6 Market Price for Each Type of Lung Cancer Liquid Biops in Korea (2018-2022)
        • 12.7 Market Price for Each Type of Lung Cancer Liquid Biops in Southeast Asia (2018-2022)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 Lung Cancer Liquid Biops Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Post-pandemic Era
        • 13.5 Technology Trends of Lung Cancer Liquid Biops

        14. Lung Cancer Liquid Biops Competitive Landscape

        • 14.1 Biocept
          • 14.1.1 Biocept Company Profiles
          • 14.1.2 Biocept Product Introduction
          • 14.1.3 Biocept Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.1.4 Strategic initiatives
        • 14.2 EntroGen
          • 14.2.1 EntroGen Company Profiles
          • 14.2.2 EntroGen Product Introduction
          • 14.2.3 EntroGen Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.2.4 Strategic initiatives
        • 14.3 Cynvenio Biosystems
          • 14.3.1 Cynvenio Biosystems Company Profiles
          • 14.3.2 Cynvenio Biosystems Product Introduction
          • 14.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.3.4 Strategic initiatives
        • 14.4 Exosome Diagnostics
          • 14.4.1 Exosome Diagnostics Company Profiles
          • 14.4.2 Exosome Diagnostics Product Introduction
          • 14.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.4.4 Strategic initiatives
        • 14.5 F. Hoffmann-La Roche
          • 14.5.1 F. Hoffmann-La Roche Company Profiles
          • 14.5.2 F. Hoffmann-La Roche Product Introduction
          • 14.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.5.4 Strategic initiatives
        • 14.6 Clearbridge BioMedics
          • 14.6.1 Clearbridge BioMedics Company Profiles
          • 14.6.2 Clearbridge BioMedics Product Introduction
          • 14.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.6.4 Strategic initiatives
        • 14.7 Bio-Rad Laboratories
          • 14.7.1 Bio-Rad Laboratories Company Profiles
          • 14.7.2 Bio-Rad Laboratories Product Introduction
          • 14.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.7.4 Strategic initiatives
        • 14.8 Agena Bioscience
          • 14.8.1 Agena Bioscience Company Profiles
          • 14.8.2 Agena Bioscience Product Introduction
          • 14.8.3 Agena Bioscience Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.8.4 Strategic initiatives
        • 14.9 Cancer Genetics
          • 14.9.1 Cancer Genetics Company Profiles
          • 14.9.2 Cancer Genetics Product Introduction
          • 14.9.3 Cancer Genetics Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.9.4 Strategic initiatives
        • 14.10 CellMax Life
          • 14.10.1 CellMax Life Company Profiles
          • 14.10.2 CellMax Life Product Introduction
          • 14.10.3 CellMax Life Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
          • 14.10.4 Strategic initiatives
        • 14.11 Nateras
        • 14.12 MedGenome
        • 14.13 OncoDNA
        • 14.14 Genomic Health
        • 14.15 Trovagene
        • 14.16 Fluxion Biosciences
        • 14.17 Biodesix
        • 14.18 Epic Sciences
        • 14.19 Shuwen Biotech
        • 14.20 Personal Genome Diagnostics
        • 14.21 Predicine

        15. Conclusion

          16. Methodology and Data Source

          Summary

          The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

          2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

          According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

          Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Lung Cancer Liquid Biops Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Lung Cancer Liquid Biops industry at home and abroad, estimate the overall market scale of the Lung Cancer Liquid Biops industry and the market share of major countries, Lung Cancer Liquid Biops industry, and study and judge the downstream market demand of Lung Cancer Liquid Biops through systematic research, Analyze the competition pattern of Lung Cancer Liquid Biops, so as to help solve the pain points of various stakeholders in Lung Cancer Liquid Biops industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

          Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Lung Cancer Liquid Biops Market by XYZResearch Include
          USA
          Europe
          China
          Japan
          India
          Korea
          Southeast Asia
          Competitive Analysis; Who are the Major Players in Lung Cancer Liquid Biops Market?
          Biocept
          EntroGen
          Cynvenio Biosystems
          Exosome Diagnostics
          F. Hoffmann-La Roche
          Clearbridge BioMedics
          Bio-Rad Laboratories
          Agena Bioscience
          Cancer Genetics
          CellMax Life
          Nateras
          MedGenome
          OncoDNA
          Genomic Health
          Trovagene
          Fluxion Biosciences
          Biodesix
          Epic Sciences
          Shuwen Biotech
          Personal Genome Diagnostics
          Predicine
          Major Type of Lung Cancer Liquid Biops Covered in XYZResearch report:
          Exosomes and RNA
          CTCs and ctDNA
          Application Segments Covered in XYZResearch Market
          Hospitals and Clinics
          Physicians'Office Laboratories
          Clinical Diagnostic Laboratories

          For any other requirements, please feel free to contact us and we will provide you customized report.

          Buy now